Nexa tech innovation offers hope for epilepsy patients

MUSCAT, FEB 24

'Onsor,' a company under the Ithca Group, launched the groundbreaking 'Nexa' technology. This breakthrough innovation marks a significant leap forward in the care of epilepsy patients, offering them a vital new tool that can predict seizures up to an hour before they occur. This invaluable prediction gives patients enough time to take the necessary preventive measures, offering a new sense of hope in managing their condition.

The official unveiling of 'Nexa' took place at the Royal Opera House in Muscat, under the auspices of HH Sayyid Dr Kamil bin Fahd bin Mahmood al Said, Secretary-General of the General Secretariat of the Council of Ministers, and in the presence of Dr Hilal bin Ali al Sabti, Minister of Health. This event drew attention to Oman's ongoing commitment to technological and health innovations that significantly impact society, particularly in the realm of epilepsy care.

'Nexa' represents a groundbreaking step in supporting epilepsy patients, as it harnesses the power of neural computing and artificial intelligence to analyse big data, accurately predicting epileptic seizures ahead of time. The ability to predict a seizure an hour before it occurs is a game-changer for patients, allowing them to take proactive steps such as seeking assistance, moving to a safe place, or preparing themselves for the impending episode, significantly reducing the health risks typically associated with sudden seizures.

Epilepsy is a condition that affects millions of people worldwide, and the unpredictable nature of seizures can severely impact a patient’s quality of life. The need for proactive solutions in this field has never been more critical, and 'Nexa' provides a timely and essential response. Studies indicate that seizure-predicting technologies such as this one can reduce the risk of injury by up to 60 per cent, providing not only physical relief but also psychological comfort for both patients and their families.

Eng Said bin Abdullah al Mandhari, CEO of Ithca Group, emphasised that supporting technological innovation is integral to the group’s broader vision of enhancing quality of life through advanced technologies. “Such initiatives reflect Ithca Group’s commitment to an ambitious vision to support innovation and progress in all fields, where the Omani person is the driver and leader of the process of transformation and development. We believe that investing in modern technologies, such as Nexa, can achieve qualitative leaps in improving the lives of individuals and communities,” he said.

Eng Muadh bin Ahmed al Hinai, CEO of Onsor, reiterated that 'Nexa' is not just a piece of technology, but a beacon of hope for millions of patients across the world. “The launch of Nexa technology embodies our commitment to developing innovative technical solutions that contribute to improving the quality of human life. We are not just talking about a technology, but about a future in which epilepsy patients can interact with their health condition consciously and proactively, which radically changes their lives,” Al Hinai said.

The event included a live demonstration of the 'Nexa' technology in action, showing how the system works to monitor patients’ health through advanced sensors and artificial intelligence algorithms. This innovative approach allows users to track their condition, reducing the frequency of sudden seizures and limiting their potentially serious consequences. The integration of AI into the technology further enhances its accuracy and effectiveness, ensuring patients receive timely warnings that empower them to manage their health more effectively.

One of the key highlights of the launch was the strategic partnership between Onsor and the Ministry of Health. This collaboration aims to leverage vast amounts of data collected by 'Nexa' to support medical research and provide invaluable insights into epilepsy treatment. The technology will also be used to provide advisory services to doctors and specialists, ensuring that patients receive the best possible care.

Experts in the field of health technology pointed out that 'Nexa' could serve as the foundation for expanding the use of neuromorphic computing in other areas of healthcare, including chronic neurological diseases and heart conditions.

The company has also expressed interest in collaborating with major international research centres and hospitals to expand the use of the technology globally, with ongoing discussions about integrating 'Nexa' into smart healthcare programmes in several countries.

The launch of 'Nexa' represents yet another milestone in Oman's vision to position itself as a regional hub for technological innovation in the healthcare sector. By providing a solution that allows epilepsy patients to regain control over their health, 'Nexa' has not only changed the lives of those directly impacted but has also opened doors for other innovative health solutions that could positively affect millions of people worldwide.

With this transformative innovation, 'Nexa' brings renewed hope to epilepsy patients, offering them the opportunity to live with greater confidence and security. The event concluded with Onsor reaffirming its commitment to developing advanced technological solutions that have a positive impact on people’s lives, further enhancing Oman’s standing as a leader in health and technology innovation.